BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Unichem Laboratories Ltd. Share Price

NSE
BSE

NSE : UNICHEMLAB

BSE : 506690

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹383.00

High

₹395.95

Price Summary

Previous Close ₹385.80
Day's Range ₹383.00 - ₹395.95
Open ₹390.00
52 Week Range ₹278.20 - ₹668.00
Volume 15,556
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 60.25
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 9.19
TTM EPS (₹) 41.89
P/E Ratio 35.47
Book Value(₹) 1.00
PAT Margin (%) 6.51
Face Value (₹) 2.00
ROCE(%) 6.34

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 4478.3 14421.6
Expenses N/A N/A
PBT 618.0 -921.8
Operating profit 0.0 0.0
Net profit 468.9 -921.8

Shareholding Pattern

Promoters (% Holding)

70.22%

Mutual funds (% Holding)

9.07%

Non-Institution (% Holding)

18.15%

FI/Banks/Insurance (% Holding)

0.25%

Government (% Holding)

0.00%

FII

1.00%

About Unichem Laboratories Ltd.

Founded 1962
Managing Director Pabitrakumar Kalipada Bhattacharyya
NSE Symbol UNICHEMLAB

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,43,229.15 1,847.30 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,78,100.22 6,708.90 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,48,250.95 4,376.45 3,101.60 - 3,101.60
Apollo Hospitals Enterprise Ltd. 1,16,391.52 8,094.85 6,677.50 - 6,677.50
Cipla Ltd. 1,08,864.87 1,347.70 1,165.70 - 1,165.70
Lupin Ltd. 1,08,721.36 2,377.90 1,836.80 - 1,836.80
Dr. Reddy's Laboratories Ltd. 1,07,942.01 1,293.00 1,138.50 - 1,138.50
Mankind Pharma Ltd. 1,00,199.63 2,427.15 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 98,526.33 1,012.45 903.00 - 903.00
Zydus Lifesciences Ltd. 94,475.31 938.00 835.50 - 835.50
no-content No Records Found

Latest News

Apr
7
2026
EQUITY Posted on Apr 7th 2026

Unichem Laboratories informs about certificate

Unichem Laboratories has informed that it enclosed a certificate dated April 3, 2026, issued by Link Intime India, Registrar & Share Transfer Agent of the Company confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Mar
30
2026
EQUITY Posted on Mar 30th 2026

Unichem Laboratories informs about scrutinizers report

Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has enclosed the result of remote e-voting in the prescribed format along with Scrutinizer's consolidated report for the following resolutions which were proposed for the approval of the Members through Postal Ballot: a. Appointment of Dr. (Ms) Swati Patankar (DIN 06594600) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2026; b. Material related party transaction(s) between Ipca Laboratories, holding company of Unichem Laboratories and Unichem Pharmaceuticals USA Inc. (Unichem USA), wholly owned subsidiary of Unichem; c. Material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. The resolutions as proposed in the postal ballot notice have been passed by the shareholders by remote e-voting process with requisite majority and are deemed to be passed on the last date of the remote e-voting period i.e. Friday, 27th March 2026. The said results and the scrutinizer’s report will be available on the Company’s website i.e. www.unichemlabs.com and that of the exchanges namely www.bseindia.com and www.nseindia.com and the website of the e-voting agency i.e. https://www.evoting.nsdl.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Mar
24
2026
EQUITY Posted on Mar 24th 2026

Unichem Laboratories informs about trading window closure

Unichem Laboratories has informed that the Trading Window for dealing in shares of the Company will be closed from Wednesday, 1st April 2026, for Designated Persons, Directors, Insiders, and their Immediate Relatives, and shall open 48 (forty-eight) hours after the financial results for the quarter and year ended 31st March 2026, are made public.
The above information is a part of company’s filings submitted to BSE.
Read More
Feb
25
2026
EQUITY Posted on Feb 25th 2026

Unichem Laboratories informs about postal ballot notice

Unichem Laboratories has informed that it enclosed the Postal Ballot Notice (‘Notice’) together with the explanatory statement seeking the approval of the members of the Company on the following Special Business items as set out in the Notice dated 5th February 2026: 1. Special resolution for approval of appointment of Dr. (Ms) Swati Patankar (DIN 06594600) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2026. 2. Ordinary resolution for approval of material related party transaction(s) between Ipca Laboratories (‘Ipca’), holding company of Unichem Laboratories (‘Unichem’) and Unichem Pharmaceuticals USA Inc. (‘Unichem USA’), wholly owned subsidiary of Unichem. 3. Ordinary resolution for approval of material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. Notice is being sent through electronic mode to those members whose e-mail addresses are registered with the Company/Depositories and whose names are recorded in the Register of Members of the Company or in the Register of Beneficial Owners maintained by the Depositories as on Friday, 20th February 2026. The notice is being sent by e-mail on 25th February 2026 to the members who have registered their e-mail IDs with Depository Participant(s) or with the Company. E-voting period will commence from Thursday, 26th February 2026, IST at 9.00 am and will end on Friday, 27th March 2026 IST at 5.00 pm. The Notice will also be available on the website of the Company at www.unichemlabs.com and on the website of the National Securities Depository (NSDL) at https://www.evoting.nsdl.com.

The above information is a part of company’s filings submitted to BSE.

Read More
May
10
2026
COMPANY Posted on May 10th 2026

Advanced Enzyme - Quaterly Results

The sales for the March 2026 quarter moved up 33.49% to Rs. 1164.10 millions as compared to Rs. 872.06 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 222.95 millions  from Rs. 110.54 millions in the quarter ended March 2026.The company reported a good operating profit of 320.18 millions compared to 187.00 millions of corresponding previous quarter.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1164.10 872.06 33.49 4527.66 3514.11 28.84 4527.66 3514.11 28.84
Other Income 51.63 45.30 13.97 633.88 614.90 3.09 633.88 614.90 3.09
PBIDT 320.18 187.00 71.22 1738.22 1321.69 31.51 1738.22 1321.69 31.51
Interest 0.60 0.77 -22.08 2.07 2.36 -12.29 2.07 2.36 -12.29
PBDT 319.58 186.23 71.61 1697.57 1319.33 28.67 1697.57 1319.33 28.67
Depreciation 31.15 31.14 0.03 120.83 114.05 5.94 120.83 114.05 5.94
PBT 288.43 155.09 85.98 1576.74 1205.28 30.82 1576.74 1205.28 30.82
TAX 65.48 44.55 46.98 258.68 181.08 42.85 258.68 181.08 42.85
Deferred Tax -2.22 9.10 -124.40 -12.01 12.22 -198.28 -12.01 12.22 -198.28
PAT 222.95 110.54 101.69 1318.06 1024.20 28.69 1318.06 1024.20 28.69
Equity 223.85 223.76 0.04 223.85 223.76 0.04 223.85 223.76 0.04
PBIDTM(%) 27.50 21.44 28.26 38.39 37.61 2.07 38.39 37.61 2.07
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Unichem Laboratories Ltd. ?

The current share price of Unichem Laboratories Ltd. is ₹385.80 as of 2026-05-08.

The market capitalisation of Unichem Laboratories Ltd. is ₹2,711.33 as of 2026-05-08.

The 1-year return of Unichem Laboratories Ltd. is 0.00% as of 2026-05-08.

The P/E ratio of Unichem Laboratories Ltd. is 35.47 as of 2026-05-10.

The 52-week high and low of Unichem Laboratories Ltd. are ₹668.00 and ₹278.20, respectively, as of 2026-05-08.

The dividend yield of Unichem Laboratories Ltd. is 0.0% as of2026-05-08.

You can buy Unichem Laboratories Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Unichem Laboratories Ltd. is Pabitrakumar Kalipada Bhattacharyya.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore